Double Good, Triple Therapy Better in Endometrial Cancer?
The fast pace of progress in endometrial cancer has taken a step forward with two trials underlining the benefit of immunotherapy plus chemo, while suggesting adding a PARP inhibitor could further boost outcomes.
Medscape Medical News
source https://www.medscape.com/viewarticle/997607?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/997607?src=rss
Comments
Post a Comment